Results

Total Results: 680 records

Showing results for "hypertension".
Users also searched for: diabetes

  1. effectivehealthcare-admin.ahrq.gov/products/mental-health-pregnancy/protocol
    January 01, 2020 - low APGAR, withdrawal, respiratory distress, neonatal intensive care unit time, persistent pulmonary hypertension … Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. … Obstetric Labor, Premature"[Mesh] OR "Persistent Fetal Circulation Syndrome"[Mesh] OR "Persistent Pulmonary Hypertension
  2. effectivehealthcare-admin.ahrq.gov/products/depression-postpartum-screening/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  3. effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  4. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-the-disabled-and-elderly-with-multiple-comorbidities-what-is-the-comparative-effectiveness-of-physician-housecalls-on-outcomes-and-total-cost
    November 01, 2017 - in 2008) Arthritis and nontraumatic joint disorders Cardiovascular disease, including stroke and hypertension
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
    June 01, 2012 - Signals Renal Artery Stenting Three independent predictors of BP response: 4) Requirement for ≥4 hypertension … Strategy: -------------------------------------------------------------------------------- 1 exp Hypertension … - Conclusions: Renal artery stenting initially improves hypertension control, but the durability
  6. effectivehealthcare-admin.ahrq.gov/products/ankyloglossia/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
    October 01, 2021 - on the prevention of cardiovascular conditions (e.g., myocardial infarction, stroke, development of hypertension
  8. effectivehealthcare-admin.ahrq.gov/products/vitamin-d-calcium/research
    December 01, 2019 - possible U-shaped association between serum 25(OH)D concentrations and both all-cause mortality and hypertension
  9. effectivehealthcare-admin.ahrq.gov/products/mental-health-pregnancy/research
    March 01, 2022 - spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary hypertension
  10. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
    July 01, 2011 - Adverse clinical outcomes associated with OSA include: cardiovascular disease, hypertension, non-insulin-dependent … index, existing non-insulin-dependent diabetes mellitus, existing cardiovascular disease, existing hypertension … index, existing non-insulin-dependent diabetes mellitus, existing cardiovascular disease, existing hypertension … The two studies of cardiovascular mortality did not have consistent findings, and the two studies of hypertension … to (continued) uncertain conclusions regarding the possible association between AHI and incident hypertension
  11. effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/policymaker
    December 01, 2019 - short lived--included Cushingoid facies, irritability/mood changes, abdominal pain, growth retardation, hypertension
  12. effectivehealthcare-admin.ahrq.gov/products/congestive-heart-failure-medicines/research
    January 01, 2020 - No therapy, except hypertension control, has been shown to reduce mortality from diastolic HF. 20 , 21 … Cardiac arrhythmias 28.1% 24 <.0001 Peripheral vascular disorder 13.6% 20 <.0001 Hypertension … (uncomplicated) 73.7% 84 <.0001 Hypertension (complicated) 8.5% 18 <.0001 Diabetes
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - positive results n fecal occult blood test; class III/IV angina or uncontrolled CHF, uncontrolled hypertension … Low: ≤ 200 mg High: >20 mg Low: ≤ 25 mg High: > 25 mg Nonspecific NSAID NR New onset hypertension … One study of rofecoxib v diclofenac reported withdrawal due to CV events (hypertension: 3/231, palpitation … Other reported AEs include oedema (v diclofenac, RR 19.20 CIL 1.17, 314.55), hypertension (v diclofenac … Other discontinuations for hypertension (2/471 v 0/473; RR 5.02 CI: 0.24, 104.31) and oedema (3/471
  14. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
    July 06, 2015 - pattern of symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal dysfunction, hypertension … Candesartan-based therapy and risk of cancer in patients with systemic hypertension (Heart Institute … of symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal dysfunction, hypertension … of symptoms), dose of the ACE inhibitor or ARB used, co-morbidities (diabetes, renal dysfunction, hypertension … of symptoms), dose of the ACE inhibitor or ARB used, co-morbidities (diabetes, renal dysfunction, hypertension
  15. S29 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s29.pdf
    October 01, 2007 - calcium-channel blockers, were widely believed to be a more effective initial therapy than thiazides for hypertension … as amlodipine, a calcium channel blocker, or lisinopril, an ACE inhibitor, for initial therapy for hypertension … vignettes, except that some subjects noted the existence of effective, relatively low cost treatments for hypertension
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
    July 01, 2013 - Systemic adverse effects of decongestants may include hypertension, tachycardia, insomnia, headaches … used with caution, if at all, in patients with diabetes mellitus, ischemic heart disease, unstable hypertension … contraindicated with coadministered monoamine oxidase inhibitors and in patients with uncontrolled hypertension … pregnancy, in children, and in those whose treatment choices are restricted due to comorbidities, such as hypertension … Nosebleeds Nasal Discomfort Bitter Aftertaste Burning Anxiety Insomnia Palpitations Dryness Hypertension
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
    July 01, 2017 - major adverse cardiac events (MACE), all-cause death, sudden cardiac death, revascularization, or highblood pressure (BP). … conducted in populations at increased risk for CVD (e.g., with diabetes, cardiometabolic syndrome, hypertension
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - Omega-3 fatty acids+fenofibrate: Incidence of hypertension among participants with high triglyceride … Vitamin E+furosemide: no significant effect on BP in pts. with essential hypertension Vitamin E+nifedipine … (960 screened); Inclusion criteria: 40-80 yrs of age; controlled or absent cholesterolemia and hypertension … Omega-3 fatty acids+fenofibrate: Incidence of hypertension among participants with high triglyceride … with essential hypertension Vitamin E+nifedipine significant decrease in total cholesterol, LDL-C,
  19. effectivehealthcare-admin.ahrq.gov/products/breastfeeding-health-outcomes/research
    March 01, 2025 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
    June 29, 2019 - analgesics (e.g., non-steroidal anti-inflammatory drugs) due to impaired liver or kidney function, hypertensionHypertension. 2004;43(3):573-577. 24. Whelton A, Fort JG, Puma JA, Normandin D, et al.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: